GLP-1 concentration: mg, mL, and syringe units

Milligrams, abbreviated mg, describe the amount of active medication. Milliliters, abbreviated mL, describe the liquid volume holding that medication. Concentration, written mg/mL, connects them: a 5 mg/mL solution contains 5 milligrams in each milliliter. Neither the bottle size nor the largest number on the label necessarily tells you your prescribed weekly dose.

On a U-100 syringe, 100 units equals 1 mL, so one unit equals 0.01 mL. These are volume markings when used for a compounded GLP-1 injection; they do not mean one milligram per unit or describe a biological activity unit of semaglutide. Confirm that the syringe supplied is actually U-100 before interpreting its scale.

The FDA compounded-semaglutide dosing-error alert explains that confusion between these measurements has contributed to overdoses. A familiar-looking syringe is not enough to ensure that the volume is right. Read the concentration and directions together every time a new vial arrives.

The arithmetic is: volume in mL = dose in mg divided by concentration in mg/mL. For a U-100 syringe only, units = volume in mL multiplied by 100. The reverse check is: syringe units divided by 100, then multiplied by concentration, equals the milligram amount.

For example, 0.5 mg divided by 2.5 mg/mL equals 0.2 mL, which equals 20 units on a U-100 syringe. The same 0.5 mg divided by 5 mg/mL equals 0.1 mL, or 10 units. Doubling concentration halves the required volume for the same dose; it does not mean your prescribed medication amount doubled.

Use this relationship to understand a label, not to overrule it. If your calculation differs from the directions, stop and ask the dispensing pharmacist and Join Luma clinician to reconcile the difference. A copied chart may use a different concentration, syringe, or formulation.

Hallandale’s supplied public catalog lists semaglutide 2.5 mg/mL in 1, 2, 3, and 4 mL vials, and 5 mg/mL in a 3 mL vial. These catalog entries are not a promise about the vial you will receive. Read your own label before comparing it with this table.

The listed milligram steps are familiar from Wegovy prescribing information, not evidence that a compounded product is interchangeable with Wegovy. Your clinician may prescribe different directions. A conversion table does not tell you when to increase a dose, whether to increase it, or what to do after side effects.

Hallandale’s supplied catalog lists tirzepatide 10 mg/mL in 1, 2, 3, and 4 mL vials, and 15 mg/mL Forte in a 4 mL vial. Forte is a concentration designation here, not permission to increase your prescribed dose. VialsRx concentrations are not published in the supplied information; your label lists the concentration.

Repeating decimals are deliberately shown rather than silently rounded. Do not estimate a fractional marking or round your own dose. Some volumes exceed the capacity of a 1 mL syringe; the 1.25 and 1.5 mL examples are arithmetic only. Ask for the correct supplies and explicit directions, and do not split an injection yourself based on this table.

A pharmacy can dispense a different concentration, vial size, or formulation at a refill. The prescribed milligram dose and the liquid volume are separate. If your previous 0.5 mg dose required 20 units at 2.5 mg/mL, continuing 20 units at 5 mg/mL would deliver 1 mg, not 0.5 mg.

Compare the medication name, added ingredients, concentration, and directions before using each new vial. Do not identify concentration by cap color or carry over the number saved in a phone reminder without checking it. The pharmacy-routing guide explains why the dispenser can also differ.

If both old and new vials are in your refrigerator, keep them clearly separated and preserve their original labels. Do not transfer contents or combine leftovers. The storage guide explains why dates and puncture limits remain important even when medication is left.

Ask the pharmacist to confirm the syringe type, capacity, and marking increments. A mathematically calculated volume may not match a supplied syringe’s practical graduations. The correct response is a clarified prescription and appropriate supplies—not guessing between lines or using an internet recommendation to round.

The CDC injection-safety guidance supports using clean technique and new sterile injection equipment. Sterility and arithmetic are separate safety checks. Read the first injection guide for preparation questions and ask the clinician for a demonstration if you are unsure how to draw the instructed volume.

Contact your clinician or dispensing pharmacist promptly if you suspect an error, and provide the concentration, amount drawn, time injected, and label directions. Do not take another injection to correct a possible mistake or create your own revised schedule. The clinician needs the exact details to advise you.

Seek urgent care for severe abdominal pain, persistent vomiting with dehydration, fainting, or other severe symptoms; call 911 for a severe allergic reaction. Routine portal response times are not an emergency plan. If you have not injected yet and the directions are unclear, resolve them before proceeding.

Join Luma support is available 24/7 through the portal or support@joinluma.com. For product context, see weekly injections. Compounded medications are not FDA-approved, and the FDA compounding overview explains why clear prescribing and dispensing instructions matter.